Impact of psychosocial factors on the conduct of combined drug and psychotherapy research

Area of Science:

• Psychiatry
• Clinical Psychology
• Medical Research

Background:

• Combined drug and psychotherapy research faces challenges due to differing professional attitudes.
• Therapist and researcher biases can influence study conduct and outcomes.
• Understanding these influences is crucial for effective clinical trial design.

Purpose of the Study:

• To examine how therapist, patient, and researcher attitudes affect combined drug and psychotherapy research.
• To assess the impact of these attitudes in a crisis-oriented psychotherapy clinic setting.

Main Methods:

• Seventy-seven patients received either an anti-anxiety drug or placebo alongside psychoanalytically-oriented psychotherapy.
• Data collection focused on patient adherence to medication, perceived importance of medication, and treatment outcomes.
• Therapist and researcher attitudes were assessed based on their actions and departmental alignment.

Main Results:

• A high percentage of patients (82%) discontinued medication, despite remaining in psychotherapy.
• Only one-third of patients felt their therapists prioritized medication adherence.
• Most patients (87%) improved and attributed their recovery primarily to psychotherapy (75%).
• Researchers, sharing therapist values, failed to enforce medication protocols, prioritizing clinic service goals.

Conclusions:

• Therapist bias towards psychotherapy significantly undermined the drug component of combined therapy research.
• Patient perceptions and adherence were heavily influenced by therapist attitudes.
• Research goals for combined therapy were thwarted, while traditional clinic services continued unaffected.